These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18847500)

  • 1. Downregulation of CD147 expression alters cytoskeleton architecture and inhibits gelatinase production and SAPK pathway in human hepatocellular carcinoma cells.
    Qian AR; Zhang W; Cao JP; Yang PF; Gao X; Wang Z; Xu HY; Weng YY; Shang P
    J Exp Clin Cancer Res; 2008 Oct; 27(1):50. PubMed ID: 18847500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA targeted against HAb18G/CD147 inhibits MMP-2 secretion, actin and FAK expression in hepatocellular carcinoma cell line via ERK1/2 pathway.
    Xu HY; Qian AR; Shang P; Xu J; Kong LM; Bian HJ; Chen ZN
    Cancer Lett; 2007 Mar; 247(2):336-44. PubMed ID: 16815629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of FAK expression inhibition by RNA interference on liver cancer cells].
    Yuan Z; Zheng Q; Huang XY; Fan J
    Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1350-3. PubMed ID: 18241574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of HAb18G/CD147 knockout on hepatocellular carcinoma cells in vitro using a novel zinc-finger nuclease-targeted gene knockout approach.
    Li HW; Yang XM; Tang J; Wang SJ; Chen ZN; Jiang JL
    Cell Biochem Biophys; 2015 Mar; 71(2):881-90. PubMed ID: 25308857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BetaIg-h3 is involved in the HAb18G/CD147-mediated metastasis process in human hepatoma cells.
    Tang J; Zhou HW; Jiang JL; Yang XM; Li Y; Zhang HX; Chen ZN; Guo WP
    Exp Biol Med (Maywood); 2007 Mar; 232(3):344-52. PubMed ID: 17327467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological changes and molecular expressions of hepatocellular carcinoma cells in three-dimensional culture model.
    Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
    Exp Mol Pathol; 2009 Oct; 87(2):133-40. PubMed ID: 19615356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A chimeric antibody targeting CD147 inhibits hepatocellular carcinoma cell motility via FAK-PI3K-Akt-Girdin signaling pathway.
    Wang Y; Yuan L; Yang XM; Wei D; Wang B; Sun XX; Feng F; Nan G; Wang Y; Chen ZN; Bian H
    Clin Exp Metastasis; 2015 Jan; 32(1):39-53. PubMed ID: 25424030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of arsenic trioxide on invasion in human hepatocellular carcinoma SMMC-7721 cells and its mechanism].
    Li HY; Cao LM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1254-7. PubMed ID: 23232515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
    Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
    Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
    Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
    Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of glucose-regulated protein 78 decreases the invasion, metalloproteinase expression and ECM degradation in hepatocellular carcinoma cells.
    Li H; Song H; Luo J; Liang J; Zhao S; Su R
    J Exp Clin Cancer Res; 2012 Apr; 31(1):39. PubMed ID: 22546345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of P53 facilitates invasion and metastasis of prostate cancer cells.
    Wang Y; Zhang YX; Kong CZ; Zhang Z; Zhu YY
    Mol Cell Biochem; 2013 Dec; 384(1-2):121-7. PubMed ID: 23982184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
    Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN
    Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of Hab18g/CD147 and activation of integrin pathway in HCC cells under 3-D co-culture conditions.
    Wu YM; Tang J; Zhao P; Chen ZN; Jiang JL
    Cell Biol Int; 2009 Feb; 33(2):199-206. PubMed ID: 19059491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway.
    Yue P; Gao ZH; Xue X; Cui SX; Zhao CR; Yuan Y; Yin Z; Inagaki Y; Kokudo N; Tang W; Qu XJ
    Eur J Cancer; 2011 May; 47(7):1115-24. PubMed ID: 21349701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRP78 promotes the invasion of pancreatic cancer cells by FAK and JNK.
    Yuan XP; Dong M; Li X; Zhou JP
    Mol Cell Biochem; 2015 Jan; 398(1-2):55-62. PubMed ID: 25218495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
    Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
    Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference targeting CD147 inhibits the invasion of human cervical squamous carcinoma cells by downregulating MMP-9.
    Fan X; Wu W; Shi H; Han J
    Cell Biol Int; 2013 Jul; 37(7):737-41. PubMed ID: 23536308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX; Chen LP; Sun MY; Li JT; Liu HZ; Zhu W
    Oncotarget; 2015 Sep; 6(27):23776-92. PubMed ID: 26068982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.